Keyphrases
Meta-analysis
88%
Chronic Kidney Disease
66%
Systematic Meta-analysis
58%
Chronic Kidney Disease Patients
40%
Cardiovascular Mortality Risk
39%
Cardiovascular Mortality
34%
Surabaya
29%
Antihypertensive Drugs
29%
Retrospective Cohort Study
29%
Referral Hospital
29%
Critically Ill COVID-19 Patients
29%
Disease Progression
29%
Myocarditis
29%
Mortality Rate
27%
COVID-19
26%
Mortality Prediction
25%
Atherosclerotic Cardiovascular Disease (ASCVD)
24%
Hypertensive
24%
Length of Stay
24%
Indonesia
24%
Clinical Characteristics
22%
Arterial Stiffness
21%
Cardiovascular Disease
21%
Acute Coronary Syndrome
21%
Confidence Interval
20%
Angiotensin-converting Enzyme Inhibitor (ACEi)
19%
Massive Pulmonary Embolism
19%
Successful Revascularization
19%
Dilated Cardiomyopathy
19%
Thrombus
19%
8-hydroxydeoxyguanosine (8-OHdG)
19%
Carotid-femoral Pulse Wave Velocity (cfPWV)
19%
Klotho
19%
Pulmonary Embolism
19%
Non-dialysis Chronic Kidney Disease
19%
Cardiogenic Shock
19%
Emergency Department
19%
Clinical Outcomes
19%
Angiotensin-converting Enzyme
19%
Interleukin-6 Levels
19%
Gene Polymorphism
19%
2 Receptor
19%
High Risk
18%
Universitas
17%
Hypertension
17%
Risk Factors
17%
Odds Ratio
16%
COVID-19 Patients
14%
Cardiac Myxoma
14%
Single nucleotide Polymorphism
13%
Medicine and Dentistry
Systematic Review
100%
Meta-Analysis
88%
Chronic Kidney Disease
50%
Cardiovascular Disease
32%
Myocarditis
29%
Diseases
22%
Acute Coronary Syndrome
21%
Cardiovascular Mortality
20%
Revascularization
19%
Dilated Cardiomyopathy
19%
Thrombus
19%
COVID-19
19%
Pulmonary Embolism
19%
Emergency Department
19%
Arterial Stiffness
19%
Cardiogenic Shock
19%
DNA Polymorphism
19%
Hemodynamic
17%
Odds Ratio
17%
Echocardiography
16%
Diagnosis
16%
Congestive Heart Failure
15%
Heart Myxoma
14%
Shock (Circulatory)
13%
Observational Study
13%
Myocardial Infarction
11%
Neoplasm
11%
Acute Decompensated Heart Failure
11%
Cross Sectional Study
11%
Oxidative Stress
10%
Patient with Obesity
9%
Bariatric Surgery
9%
Atrial Fibrillation
9%
Homocysteine
9%
Carotid Atherosclerosis
9%
Circulating microRNA
9%
Pulmonary Valve
9%
Artery Calcification
9%
Chylopericardium
9%
Fibroblast Growth Factor 23
9%
Pericardiocentesis
9%
Low Drug Dose
9%
Coronavirinae
9%
Biological Marker
9%
Patient with Non-Hodgkins Lymphoma
9%
N(g),n(g) Dimethylarginine
9%
Hypovitaminosis D
9%
Vitamin D Deficiency
9%
Tamponade
9%
Receptor
9%